Chair of the 4th HEMNET Forum - Mohammed El-Khorassani (Morocco)
Chair of the HEMNET Group - Magdy El-Ekiaby (Egypt)
President of AMH - Lahsen Mrani Alaoui (Morocco)
WFH Chief Executive Office - Alain Baumann (Canada)
Ministry of Health and Social Protection of Morocco
ABOUT HEMNET
The Hemophilia Eastern Mediterranean Network (HEMNET) is a network of leading all healthcare professionals established in December 2017 under the umbrella of the World Federation of Hemophilia (WFH).
| HEMNET Steering Committee (SC) | ||
|---|---|---|
| SC Chair | Magdy El-Ekiaby | Egypt |
| SC Regional Members |
|
|
| SC International Members |
|
WFH Vice President, Medical University Of Milan |
ABOUT THE 2022 HEMNET FORUM
HEMNET is organizing its Fourth Annual HEMNET Forum. The Forum will take place at the Barcelo Hotel in Morocco, Casablanca on November 3 - 5, 2022. Target Audience includes all healthcare professionals interested to the bleeding disorders from all countries.
| Fourth HEMNET Forum 2022 Scientific/Organizing Committee | ||
|---|---|---|
| Forum Chair | Mohamed El Khorassani | Morocco |
| Forum Scientific Committee |
|
|
| Forum Organizing Committee |
|
|
Please save the date and register as soon as possible to confirm your presence
You can still introduce modifications until Octobre 9th, 2022, 12:00am, by login to your session
-
03 Nov
-
04 Nov
-
05 Nov
- SESSION I
- SESSION II
- SESSION III
- SESSION IV
Life Journey of a PWH: Personalized Treatment
Miftah Al-Sahati (Libya)
Hadeel Saleh (Kuwait)
Selim Nekkal (Algeria
Immune Tolerance Induction (ITI)
Real World Data Responses to Key Clinical Questions Relating to Haemophilia A Management
HTC perspective -- Frederica Cassis (Brazil)
PWH Perspective -- Walid Qubaisi (UAE)
- SESSION V
- SESSION VI
- SESSION VII
- SESSION VIII
- SESSION IX
- SESSION X
Rare Bleeding Disorders
FXIII Deficiency - Tahani Ali (Syria)
Afibrinogenemia - Claudia Khayat (Lebanon)
Glanzmann Thrombasthenia - Ons Ghali (Tunisia)
VWD Type 3 - Tahira Zafar (Pakistan)
Status of Rare Hemostasis Disorders in the Middle East: How Do We Keep Up with the Times?
Introduction - Mohamed El Khorassani
Current Models of Hemophilia Care in Middle East - Magdy Ekiaby (Egypt)
VWD: Need for Better Diagnosis and Management - Claudia Khayat (Lebanon)
Overview of Congenital Dysfibrinogenemia - Emna Gouider (Tunisia)
Q&A session: Panelists
Factor VII - Sarra Benmiloud (Morocco)
Fibrinogen - Claudia Khayat (Lebanon)
Factor XIII - Akbar Dorgalaleh (Iran)
Factor X - Safaa Mohammad (Iraq)
Factor VII -- Sara Benmiloud (Morocco)
Fibrinogen -- Claudia Khayat (Lebanon)
Factor XII -- Akbar Dorgalaleh (Iran)
Factor X -- Safaa Mohammad (Iraq)
Factor X Deficiency
Hemophilic Arthropathy: Objective Scores for Assessment - Ilham Youssry (Egypt)
Menorrhagia in Egyptian Adolescent Girls with Inherited Bleeding Disorders: A Single Centre Study - Magy Abdelwahab (Egypt)
Difficulty of Hemophilia Care in Developing Countries: Experience of the Hemophilia Centre at the Mohammed VI University Hospital in Marrakech - Rajaa Tissir (Morocco)
Pediatric Population of PWH at the Hemophilia Treatment Center of Aziza Othmana Hospital - Sarra Fekih Salem (Tunisia)
Low dose Prophylaxis: After 10 Years of Follow-up - Ons Ghali (Tunisia)
Molecular Defects of Congenital Deficiencies of Fibrinogen in Tunisia - Hejer Elmahmoudi (Tunisia)
Acquired Hemophilia “A” Associated with Anti-Phospholipid Syndrome: A Case Report - Rajaa Tissir (Morocco)
For assistance contact HEMNET conference secretariat
HEMNET 2022 Secretariat
M. Haroun Bizid
Warm Regards
The HEMNET FORUM 2022 Steering Committee